BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1457125)

  • 1. Molecular genetics of leukemia inhibitory factor (LIF) and its receptor.
    Gough NM
    Growth Factors; 1992; 7(3):175-9. PubMed ID: 1457125
    [No Abstract]   [Full Text] [Related]  

  • 2. The leukemia inhibitory factor and its receptor.
    Gearing DP
    Adv Immunol; 1993; 53():31-58. PubMed ID: 8512038
    [No Abstract]   [Full Text] [Related]  

  • 3. Close proximity of the genes for leukemia inhibitory factor and oncostatin M.
    Jeffery E; Price V; Gearing DP
    Cytokine; 1993 Mar; 5(2):107-11. PubMed ID: 8334225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tandem linkage of genes coding for leukemia inhibitory factor (LIF) and oncostatin M (OSM) on human chromosome 22.
    Giovannini M; Djabali M; McElligott D; Selleri L; Evans GA
    Cytogenet Cell Genet; 1993; 64(3-4):240-4. PubMed ID: 8404048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Function, molecular structure and gene expression regulation of receptor for D-factor/LIF].
    Tomida M
    Nihon Rinsho; 1992 Aug; 50(8):1956-61. PubMed ID: 1433987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncostatin M binds the high-affinity leukemia inhibitory factor receptor.
    Gearing DP; Bruce AG
    New Biol; 1992 Jan; 4(1):61-5. PubMed ID: 1536831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LIF: lots of interesting functions.
    Hilton DJ
    Trends Biochem Sci; 1992 Feb; 17(2):72-6. PubMed ID: 1566332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor.
    Plun-Favreau H; Perret D; Diveu C; Froger J; Chevalier S; Lelièvre E; Gascan H; Chabbert M
    J Biol Chem; 2003 Jul; 278(29):27169-79. PubMed ID: 12707269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.
    Anhuf D; Weissenbach M; Schmitz J; Sobota R; Hermanns HM; Radtke S; Linnemann S; Behrmann I; Heinrich PC; Schaper F
    J Immunol; 2000 Sep; 165(5):2535-43. PubMed ID: 10946280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Leukemia inhibitory factor and its physiological functions during embryo development and blastocyst implantation].
    Zhang CY; Duan EK; Zeng GQ
    Sheng Li Ke Xue Jin Zhan; 1997 Jul; 28(3):240-2. PubMed ID: 11038733
    [No Abstract]   [Full Text] [Related]  

  • 11. The genes for oncostatin M (OSM) and leukemia inhibitory factor (LIF) are tightly linked on human chromosome 22.
    Rose TM; Lagrou MJ; Fransson I; Werelius B; Delattre O; Thomas G; de Jong PJ; Todaro GJ; Dumanski JP
    Genomics; 1993 Jul; 17(1):136-40. PubMed ID: 8406444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Leukemia inhibitory factor: a novel cytokine with multiple function].
    Wang FS; Wu ZZ
    Sheng Li Ke Xue Jin Zhan; 1993 Jan; 24(1):18-22. PubMed ID: 8332863
    [No Abstract]   [Full Text] [Related]  

  • 13. Oncostatin M is a differentiation factor for myeloid leukemia cells.
    Bruce AG; Hoggatt IH; Rose TM
    J Immunol; 1992 Aug; 149(4):1271-5. PubMed ID: 1380037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
    Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
    J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstitution of the response to leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in hepatoma cells.
    Baumann H; Ziegler SF; Mosley B; Morella KK; Pajovic S; Gearing DP
    J Biol Chem; 1993 Apr; 268(12):8414-7. PubMed ID: 7682551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of oncostatin M and leukaemia inhibitory factor expression in astrocytoma cells.
    Kasza A; Rogowski K; Kilarski W; Sobota R; Bernas T; Dobrucki J; Travis J; Koj A; Bugno M; Kordula T
    Biochem J; 2001 Apr; 355(Pt 2):307-14. PubMed ID: 11284716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of leukemia inhibitory factor during mammalian development.
    Shellard J; Perreau J; Brûlet P
    Eur Cytokine Netw; 1996 Dec; 7(4):699-712. PubMed ID: 9010672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
    J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor.
    Gearing DP; Comeau MR; Friend DJ; Gimpel SD; Thut CJ; McGourty J; Brasher KK; King JA; Gillis S; Mosley B
    Science; 1992 Mar; 255(5050):1434-7. PubMed ID: 1542794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.